HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 144 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,884,000 | -44.8% | 544,653 | -17.4% | 0.55% | -10.7% |
| Q1 2022 | $12,471,000 | -43.4% | 659,133 | +4.9% | 0.62% | -41.3% |
| Q4 2021 | $22,047,000 | -4.2% | 628,477 | 0.0% | 1.05% | -48.3% |
| Q3 2021 | $23,009,000 | +7.0% | 628,477 | +14.7% | 2.04% | +9.5% |
| Q2 2021 | $21,510,000 | +39.0% | 547,743 | 0.0% | 1.86% | +25.8% |
| Q1 2021 | $15,474,000 | -15.3% | 547,743 | -4.0% | 1.48% | -22.6% |
| Q4 2020 | $18,267,000 | -2.0% | 570,500 | -1.1% | 1.91% | -16.5% |
| Q3 2020 | $18,631,000 | +12.7% | 576,818 | -3.8% | 2.29% | +4.0% |
| Q2 2020 | $16,535,000 | +43.2% | 599,528 | -7.3% | 2.20% | +4.6% |
| Q1 2020 | $11,545,000 | -23.4% | 646,792 | +7.6% | 2.10% | -10.1% |
| Q4 2019 | $15,064,000 | +3.8% | 600,892 | -26.1% | 2.34% | -6.5% |
| Q3 2019 | $14,511,000 | -13.3% | 813,392 | +6.9% | 2.50% | +7.0% |
| Q2 2019 | $16,746,000 | -5.2% | 761,171 | +31.7% | 2.34% | +5.8% |
| Q1 2019 | $17,668,000 | – | 577,755 | – | 2.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 421,140 | $5,075,000 | 10.46% |
| Capital International, Inc./CA/ | 4,151,900 | $52,480,000 | 0.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 859 | $68,000,000 | 0.71% |
| GENERAL ATLANTIC, L.P. | 4,000,000 | $50,560,000 | 0.66% |
| Capital International Sarl | 544,653 | $6,884,000 | 0.55% |
| M&G INVESTMENT MANAGEMENT LTD | 6,977,228 | $90,704,000 | 0.54% |
| E Fund Management (Hong Kong) Co., Ltd. | 58,861 | $744,000 | 0.51% |
| Bellevue Group AG | 1,756,307 | $21,359,000 | 0.30% |
| AIA Group Ltd | 356,640 | $4,508,000 | 0.24% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 224,634 | $2,839,000 | 0.11% |